AnalystsOren LivnatOren Livnat's Stock Forecasts
AnalystsOren Livnat
Analyst Ranking
Bottom 7%
#4260 out of 4565 analysts
Average Return
-3.58%
Win Rate
36%43 out of 121
Risk vs Reward
Poor
Good
Oren Livnat's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Avadel Pharmaceuticals PLCAVDL | +453.60% | $2.50 | $13.84 | 2022-05-27 - 2023-05-26 | Buy |
Verrica Pharmaceuticals IncVRCA | +175.65% | $1.93 | $5.32 | 2022-05-31 - 2023-05-30 | Buy |
Aerie Pharmaceuticals IncAERI | +162.18% | $5.79 | $15.18 | 2022-05-09 - 2022-08-24 | Buy |
Tarsus Pharmaceuticals IncTARS | +114.19% | $13.74 | $29.43 | 2023-03-15 - 2024-03-14 | Buy |
Mannkind CorpMNKD | +105.34% | $2.62 | $5.38 | 2022-02-28 - 2023-02-27 | Buy |
Oren Livnat Analyst Color
Get additional color on Oren Livnat's coverage of popular stocks
Oren Livnat's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Zevra Therapeutics IncZVRA | 7 | Buy | $15.00 | +231.86% | Reiterates | 24 days ago |
Jazz Pharmaceuticals PLCJAZZ | 12 | Buy | $200.00 | +86.17% | Maintains | a month ago |
Xeris Biopharma Holdings IncXERS | 7 | Buy | $6.00 | +252.94% | Maintains | 2 months ago |
Avadel Pharmaceuticals PLCAVDL | 9 | Buy | $25.00 | +40.29% | Maintains | 2 months ago |
Pacira Biosciences IncPCRX | 13 | Buy | $57.00 | +123.53% | Reiterates | 2 months ago |
Ani Pharmaceuticals IncANIP | 6 | Buy | $83.00 | +27.79% | Maintains | 2 months ago |
Verrica Pharmaceuticals IncVRCA | 8 | Buy | $13.00 | +95.49% | Maintains | 2 months ago |
Tarsus Pharmaceuticals IncTARS | 7 | Buy | $57.00 | +76.96% | Maintains | 2 months ago |
Mannkind CorpMNKD | 6 | Buy | $7.50 | +79.43% | Reiterates | 4 months ago |
Cara Therapeutics IncCARA | 8 | Buy | $2.50 | +257.14% | Maintains | 4 months ago |
Agile Therapeutics IncAGRX | 9 | Buy | $12.00 | +1,893.36% | Reiterates | 10 months ago |
Satsuma Pharmaceuticals IncSTSA | 4 | Buy | $3.00 | N/A | Reiterates | a year ago |
Acasti Pharma IncACST | 1 | Buy | $14.40 | N/A | Initiates Coverage On | a year ago |
Aerie Pharmaceuticals IncAERI | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Novan IncNOVNQ | 6 | Buy | $17.00 | N/A | Maintains | 2 years ago |
Collegium Pharmaceutical IncCOLL | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Otonomy IncOTIC | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Scynexis IncSCYX | 2 | Buy | $8.00 | N/A | Maintains | 2 years ago |
Antares Pharma IncATRS | 3 | Hold | $5.60 | N/A | Downgrades | 2 years ago |
Biodelivery Sciences International IncBDSI | 5 | Hold | $4.50 | N/A | Maintains | 2 years ago |
Lipocine IncLPCN | 5 | Buy | $59.50 | N/A | Maintains | 3 years ago |
Taiwan Liposome Company LtdTLC | 2 | Hold | $7.50 | N/A | Downgrades | 3 years ago |
Vyne Therapeutics IncVYNE | 2 | Buy | $198.00 | N/A | Maintains | 3 years ago |
Corium International IncCORI | 2 | Hold | $13.00 | N/A | Downgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.